TRACY LUTCHE: Open Payments
NPI 1609332485 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 12 payments from 4 companies in 2025. Trend: 2023 $817 · 2024 $641 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $228 |
| Otsuka America Pharmaceutical, Inc. | 3 | $158 |
| E.R. Squibb & Sons, L.L.C. | 2 | $148 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
Products named: CAPLYTA, COBENFY, REXULTI, ABILIFY ASIMTUFII, INGREZZA.
Industry payments across CA — which companies pay providers there.
